SOX21 and Nephroblastoma: As shown in the Figure 2A–C, nephroblastoma patients with ≥5 cm, III-IV or unfavorable had profoundly higher SOX21-AS1 expression levels than nephroblastoma patients with <5 cm, I-II or favorable, respectively.